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Abstract
Full circumferential segmental bone loss of the tibia
presents a challenge to orthopaedic surgeons. These open
fractures often involve extensive soft-tissue damage, which
can contribute to poor long-term outcomes even if the tibia
is successfully reconstructed. Although amputation was
historically used to treat full circumferential segmental
bone loss of the tibia because of the severity of the injury,
the development of new reconstruction procedures has
provided the option of limb salvage techniques. I reviewed
studies on treatment of traumatic tibia bone loss, focusing
particularly on full circumferential bone loss of greater than
3 cm. Treatment options included amputation, allograft
replacement, autologous bone grafting, use of vascularized
fibular autograft, bone transport, and the Masquelet
(induced membrane) technique. The most commonly used
methods of limb salvage for treating full circumferential
segmental bone loss are bone transport, use of vascularized
fibular autograft, and the induced membrane method.
Successful treatment, however, can depend on individual
comfort levels of patients and physicians when deciding
between the different approaches.

Introduction
A standard definition of segmental bone loss is not clearly
stated nor agreed on by most authors, but two classification
systems for the condition exist. Robinson et al1 presented
one of the first systems that organized bone loss into trivial,
minor, moderate, and severe categories based on increasing
size of defect shape (wedged or circumferential) and length.
In this classification system, partial and full circumferential
bone loss were often placed in the same category. Other
classification systems include the Orthopaedic Trauma
Association2 classification of open fractures, which
takes into account bone loss and other factors such as
contamination. This system differentiates between full and
partial circumferential bone loss.
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Full circumferential bone loss of the tibia commonly
results from traumatic injuries (either acute bone loss or after
debridement of contaminated or devitalized bone), chronic
osteomyelitis, nonunion, and tumor resection.3 These
traumatic injuries are often encountered in male patients
after motor vehicle collisions, motorcycle accidents, gunshot
wounds, falls, and crush injuries.4,5,6 The resulting open
fractures (classified as Gustilo-Anderson grade IIIA or IIIB)
usually occur in the tibia owing to its limited anterior softtissue envelope and subsequently can involve severe softtissue damage that necessitates coverage with either a free
flap or rotational myoplasty.5,7,8 Additionally, the decision to
perform debridement for treating an open fracture requires
careful consideration because contaminated bone increases
the risk of infection but aggressive removal may increase
the size of the defect.7,9
The choice of treatment method typically depends on the
length of the defect resulting from bone loss.10 Shortening
is generally used for treating defects less than 1 cm in
length, which can create bony contact at the fracture site
to encourage healing.11 Fractures are treated with fixation
(with or without bone grafting) to fill defects greater than
1 cm but less than 3 cm.11,6 However, defects greater than
3 cm in length do not currently have a standard method
of treatment. I reviewed treatment options for these larger
defects, including amputation, allograft replacement,
autologous bone grafting, use of vascularized fibular
autograft, bone transport, and the Masquelet technique.

Older Treatment Options
Amputation
Indicators for primary amputation for treatment of open
tibial fractures have included hemodynamic instability,
partial amputation, more than 6 hours of ischemia time,
a Mangled Extremity Severity Score of seven or greater,
and transection of the tibial nerve.12 Loss of tibial nerve
sensation, once thought as an indicator, has been reported
to return several months after the injury.13

Complications after limb salvage that necessitate
amputation have included persistent infection, ipsilateral
injuries, vascular injuries, and discontinued long-term use
of an external fixator device or a frame.14,15 In a retrospective
study on clinical and functional outcomes of limb salvage,
Mekhail et al4 described shorter operating times but higher
lifetime costs16 for patients treated with amputation. In
general, patients who underwent amputation later in their
life may have been influenced by factors such as depression,
divorce, and destitution after spending considerable time
and resources on failed limb reconstruction techniques.15
Allograft Replacement
Described in primarily oncological applications, the use
of structural allograft has involved high rates of infection,
stress fractures related to the graft, nonunion at the boneallograft interface, and extended periods of time required
for creeping substitution of new bone.17 Chmell et al18
found infection rates of 40% and amputation rates of 12.5%
with use of allograft in the tibia. Although unreliable, the
functional outcomes were good if the graft was successfully
incorporated. Additionally, in a 24-year retrospective study,
Sorger et al19 reported allograft fracture rates of 18.7% in
the tibia at about 3.2 years after placement. These longterm complications have generally prevented allograft
replacement from being a common treatment of acute
traumatic injuries and associated bone loss.
Autologous Bone Grafting
Posterolateral bone grafting was described in a study
by Harmon20 in 1945 as one of the first reliable salvage
techniques that could avoid damaged anterior soft-tissues,
which had been a notable limitation before the use of freeflap coverage. Large amounts of grafting material were used
in a posterior approach to the tibia, fibula, and interosseous
membrane to help create synostosis between the tibia and
fibula. However, successful treatment (about 40-50 weeks
to consolidation) required more time than the anterolateral
approach and lifetime bracing was often necessary because
of injury-related damage to the membrane.
Direct anterolateral grafting became a viable option after
the development of microvascular surgery, which allowed
soft-tissue transfers to cover the anterior tibia defect. This
soft-tissue flap coverage decreased the risk of infection and
provided a well-vascularized environment for consolidation.
Additionally, the use of external or internal fixators before
grafting has provided stability to the construct. Watson et
al5 noted shorter total healing times, with external fixation
achieved at about 5.5 months and full weight bearing
possible at 4 months after fixator removal. Christian et al21

also used this technique and found large defects to heal after
9 months. Absorption of the grafting material did occur in
some cases, requiring repeated grafting.

Modern Treatment Options
Use of a Vascularized Fibular Autograft
Vascular anastomosis with the anterior tibial artery could
be achieved by transferring harvested contralateral or
ipsilateral fibula to the defect, with the graft secured using
screw or screw-plate fixation at the donor site and the use
of an external fixator device during healing. Zhen et al5
recommended use of harvested grafts greater by 2 cm or
more in length than the defect to allow proximal and distal
placement of the fibula inside of the tibia and completed
fixation. After healing and removal of the external fixator
device, a study by El-Gammal et al10 described use of bracing
to shelter the graft and allow partial weight bearing, which
protected the construct while waiting for hypertrophy of
the graft to occur.
Advantages of this treatment have included decreased
infection rates owing to the immediate presence of
viable bone after autograft transplant; the ability to use
accessible osteoseptocutaneous grafts to simultaneously
treat associated soft-tissue defects; short operating times
of external fixation; and time to full weight bearing
depending on hypertrophy rather than the length of the
bony defect.5,10,22,23 Drawbacks involved the typical need for
a microvascular surgeon; short-term complications such as
vascular occlusion; donor-site morbidity, stress fractures
in the fibular graft because the bone went from minimal
to primary weight bearing; and transient peroneal nerve
palsies.5,22
Bone Transport
A study by Ilizarov and Ledyaev24 was the first to describe a
bone transport technique after debridement, healing of the
soft-tissue envelope, transition from a traditional external
fixator device to an Ilizarov frame, and corticotomy. The
transported bone was “docked” at the opposite end of the
defect (with or without bone grafting), and the frame was
removed after both consolidation of bone and healing had
occurred. However, both the rate of healing in the docking
site and consolidation of the bone limited the success of
treatment.
Studies on bone transport have shown promising results.
Rates of 0.5 mm to 1 mm of bone transport per day has
started 5 days to 7 days after corticotomy, with at most
four individual adjustments daily.25,14 Time required for
external fixation has been reported between 10.6 months to
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16 months.10,14 El-Gammal et al10 reported the average time
to full weight bearing with use of bone transport at 11.8
months, with good to excellent results in 91% to 95% of acute
traumatic injuries. However, 50% of patients had major
complications that involved knee flexion contractures,
loss of ankle motion, and malalignment. Lowenberg et al14
reported a low nonunion rate of 8.8% after grafting the
docking site, with at most 27% and 18% of patients requiring
a cane or ankle-foot orthoses for ambulation, respectively.
Many adjustments have been made to improve this
technique. Transport over an IM nail has decreased the rate
of malunion and total time necessary to use the frame.26,27
Although shortening techniques have been limited because
of possible vascular compromise, Sen et al28 recommended
and performed a maximum cut of 3 cm followed by
lengthening for successfully treating a large defect.
Additionally, a vascular study by Atbasi et al29 showed
development of tortuosity resulting from greater than 4 cm
of acute shortening.
However, El-Rosasy30 found that the restrictions of acute
shortening depended mainly on location chosen in the
bone with the defect, and another study31 described 10.3
cm of acute shortening without vascular complication.
Using pulsed ultrasound, Gold and Wasserman32 noted
decreased time required for healing and consolidation, with
an external fixation time of 13.9 months and an external
fixation index of 1.3 months/cm for acute injuries. In this
study, patient medical history such as smoking, infection,
and nonunion before surgery may have contributed to
poorer treatment outcomes.
Masquelet Technique
The most recent method for treatment of large segmental
defects was a procedure described by Masquelet et al,33 known
as either the induced membrane technique or Masquelet
technique. This technique involved at least two steps, the
first being debridement of the bone defect and placement
of an antibiotic spacer made of polymethylmethacrylate
(PMMA). The tibia could be stabilized when the cement
spacer was placed, or earlier using either an IM nail or
plate. About 4 weeks to 8 weeks later, the PMMA spacer
was removed while carefully preserving encompassing
membrane and the defect was filled with osteoinductive and
osteoconductive additives. The membrane was carefully
closed over the grafting material and allowed to consolidate
with the bone. Because this technique was relatively simple,
special training was not required.
The use of an induced membrane was a major difference
from traditional anterolateral grafting. This helped
successful treatment by preventing fibrous ingrowth into
the area of the bony defect and resorption of the graft after
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placement. Additionally, an in vitro study by Aho et al34
reported that the membrane was a source of osteoinductive
factors, including bone morphogenetic protein-2, which
peaked in production at 4 weeks and decreased thereafter.
Use of the membrane also caused differentiation into
the osteoblastic lineage, helping bone formation and
consolidation at the site of the defect. No external fixators
were needed for most of these fractures, which avoided pin
tract infections and difficulties of living associated with the
device.
Studies have been mainly limited to short-term results.
A study of acute trauma, infection, and nonunions by
Donegan et al35 reported that 90% of patients had complete
healing of the defect, with about 133 days and 266 days after
fixation required for full weight bearing and consolidation
of the bone graft, respectively. Another study36 described the
Masquelet technique in treating a defect greater than 10 cm
in length, which resulted in full weight bearing and removal
of the external fixator at 10 months and no long-term
complications. Biau et al37 also noted successful treatment
of long-bone segmental defects with the technique. In
a review on defects ranging from 3.4 cm to 10.4 cm in
length treated with a modified Masquelet technique using
antibiotic beads, Ristiniemi et al7 found that healing time
did not depend on the length of the defect, although distal
healed faster than proximal tibia defects and diaphyseal
defects were the slowest to heal.

Conclusion
Bone transport, use of a vascularized fibular autograft, and
the Masquelet technique are reliable methods for treating
defects greater than 3 cm in length. Both bone transport
and the use of a vascularized fibular autograft require
specialized training for successful treatment, but commonly
necessitate the use of long-term external fixator devices
that further complicate treatment. Bone transport and the
Masquelet technique induce bone formation, which is often
similar in size to native bone, whereas vascularized fibular
grafts require hypertrophy of the graft. The Masquelet
technique has shown some promising results; however,
further studies are needed to verify its effectiveness for
treatment. Ultimately, the decision of which approach to
employ depends on surgeon comfort level with each specific
technique.
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